Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | GALR3 | O60755 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL199577 | 0.96 | TSHR (0.43) | TSHRALDH1A1CHRM2CHRM4CHRM1 | |
| Bromide SCHEMBL1303379 | 0.94 | TSHR (0.42) | TSHRALDH1A1CHRM2CHRM4CHRM1 | |
| Fluoride Ion SCHEMBL1302806 | 0.94 | TSHR (0.42) | TSHRALDH1A1CHRM2CHRM4CHRM1 | |
| Iodide SCHEMBL1302484 | 0.94 | TSHR (0.42) | TSHRALDH1A1CHRM2CHRM4CHRM1 | |
| Ammonia Solution, Strong SCHEMBL27731576 | 0.94 | TSHR (0.42) | TSHRALDH1A1CHRM2CHRM4CHRM1 | |
| Hydrochloric Acid SCHEMBL15953 | 0.94 | TSHR (0.42) | TSHRALDH1A1CHRM2CHRM4CHRM1 | |
| Methylamine SCHEMBL28548539 | 0.92 | TSHR (0.41) | TSHRALDH1A1CHRM2CHRM4CHRM1 | |
| Iodide SCHEMBL27827605 | 0.92 | TSHR (0.41) | TSHRALDH1A1CHRM2CHRM4CHRM1 | |
| Ammonia Solution, Strong SCHEMBL27752179 | 0.92 | TSHR (0.41) | TSHRALDH1A1CHRM2CHRM4CHRM1 | |
| Hydrochloric Acid SCHEMBL29091412 | 0.92 | TSHR (0.41) | TSHRALDH1A1CHRM2CHRM4CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1500744-B9 | PAPER-MAKING ADDITIVE AND METHOD FOR PRODUCING PAPER | NOF CORP (JP) | 2009-11-11 | — | — | EP | disclosed |
| EP-1500744-B1 | PAPER-MAKING ADDITIVE AND METHOD FOR PRODUCING PAPER | NOF CORP (JP) | 2008-12-31 | — | — | EP | disclosed |
| US-7344621-B2 | Paper additive composition and method for producing paper using the same | NOF CORPORATION (JP) | 2008-03-18 | — | — | US | disclosed |
| EP-1500744-A2 | PAPER-MAKING ADDITIVE AND METHOD FOR PRODUCING PAPER | NOF CORPORATION (JP) | 2005-01-26 | — | — | EP | disclosed |
| US-20040188047-A1 | Paper additive composition and method for producing paper using the same | NOF CORPORATION | 2004-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040188047-A1 | Paper additive composition and method for producing paper using the same | PRMT1, SAT1, H1-0 | TSHR 1564/4885ALDH1A1 1212/4885CHRM2 515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.